Professor of Medicine, Massachusetts General Hospital
Endocrinology
Dr. Steven K. Grinspoon, MD
|
|
Give Review
Steven K. Grinspoon, MD is an expert in the field of Endocrinology. He researched medicine at University of Rochester School of Medicine and Dentistry. He over the years received 1 awards: "Elected Member". Doctor Steven K. Grinspoon, MD is also a published doctor. He has 73 publication published. The most recent publication is: Pathophysiology and management of cardiovascular disease in patients with HIV. Steven Grinspoon is registered with Medicare.
Publications
- The past 10 years-new Hormones, new functions, new endocrine organs.
- Effects of Growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies.
- Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine.
- High-density lipoprotein-mediated cholesterol efflux capacity is improved by treatment with antiretroviral therapy in acute human immunoDeficiency virus infection.
- Imaging atherosclerotic burden and inflammation: Insights into the spectrum of atherosclerotic disease in HIV.
- Risk of coronary heart disease in patients with HIV infection.
- Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort.
- Soluble CD163 is Associated with Shortened Telomere Length in HIV-infected Patients.
- 2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without ...
- Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Clinical Trial.
- Epicardial adipose tissue and atherogenesis: EAT your heart out.
- Increased Arterial Inflammation Relates to High-Risk Coronary Plaque Morphology in HIV-Infected Patients.
- HDL redox activity is increased in HIV-infected men in association with macrophage activation and noncalcified coronary atherosclerotic plaque.
- Metabolic and Body Composition Effects of Newer Antiretrovirals in HIV-Infected Patients.
- Discordance of IGF-1 and GH stimulation testing for altered GH secretion in obesity.
- Measurement of Arterial Activity on Routine FDG PET/CT Images Improves Prediction of Risk of Future CV Events.
- The Effects of Tesamorelin on Phosphocreatine Recovery in Obese Subjects with Reduced GH.
- Noncalcified Coronary Atherosclerotic Plaque and Immune Activation in HIV-infected Women.
- Increased hot flash severity and related interference in perimenopausal human immunoDeficiency virus-infected women.
- Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents.
- Increased Coronary Atherosclerotic Plaque Vulnerability by Coronary Computed Tomography Angiography in HIV-Infected Men.
- Metabolic effects of a Growth hormone-releasing factor in obese subjects with reduced Growth hormone secretion: a randomized controlled trial.
- Increased FDG uptake in association with reduced extremity fat in HIV patients.
- Increased Coronary Atherosclerosis and Immune Activation in HIV-1 Elite Controllers.
- Effects of aging and smoking on carotid intima media thickness in HIV-infection.
- Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity.
- Receptor activator of nuclear factor kappa β ligand (RANKL) and its relationship to coronary atherosclerosis in HIV patients.
- Arterial inflammation in patients with HIV.
- Metabolic and cardiovascular complications in HIV-infected patients: new challenges for a new age.
- Body Composition and Metabolic Changes in HIV-Infected Patients.
- Reduction in Visceral Adiposity Is Associated With an Improved Metabolic Profile in HIV-Infected Patients Receiving Tesamorelin.
- Relationship between Monocyte/Macrophage Activation Marker Soluble CD163 and Insulin Resistance in Obese and Normal-Weight Subjects.
- Skeletal Muscle Mitochondrial Function Is Associated with Longitudinal Growth Velocity in Children and Adolescents.
- Estrogen Sulfotransferase Is Expressed in Subcutaneous Adipose Tissue of Obese Humans in Association with TNF-{alpha} and SOCS3.
- Effects of Tesamorelin on Inflammatory Markers in HIV Patients with Excess Abdominal Fat: Relationship with Visceral Adipose Reduction.
- Associations of cardiovascular risk factors with two surrogate markers of subclinical atherosclerosis: endothelial function and carotid intima media thickness.
- Relationship between neck circumference and cardiometabolic parameters in HIV-infected and non-HIV-infected adults.
- The association of Growth hormone parameters with skeletal muscle phosphocreatine recovery in adult men.
- Immune dysregulation and vascular risk in HIV-infected patients: implications for clinical care.
- Effects of a Growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men.
- TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabol...
- Association of Immunologic and Virologic Factors With Myocardial Infarction Rates in a US Healthcare System.
- Skeletal muscle phosphocreatine recovery after submaximal exercise in children and young and middle-aged adults.
- Effect of body mass index on peak Growth hormone response to provocative testing in children with short stature.
- Mitochondrial function and insulin resistance in overweight and normal-weight children.
- Reduced Growth hormone secretion is associated with increased carotid intima-media thickness in obesity.
- Association of C-reactive protein and HIV infection with acute myocardial infarction.
- Decreased respiratory quotient in relation to resting energy expenditure in HIV-infected and noninfected subjects.
- GH/GHRH axis in HIV lipodystrophy.
- The effects of central adiposity on Growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men.
- Fracture prevalence among human immunoDeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.
- State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary.
- Relation of body composition to body mass index in HIV-infected patients with metabolic abnormalities.
- A dural tale.
- Adipose compartmentalization and insulin resistance among obese HIV-infected women: the role of intermuscular adipose tissue.
- Vascular Dysfunction and cardiovascular complications.
- Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome.
- Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunoDeficiency virus disease.
- Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical T...
- Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults.
- Determinants of skeletal loss and recovery in anorexia nervosa.
- Effects of obesity, body composition, and adiponectin on carotid intima-media thickness in healthy women.
- Effects of etanercept in patients with the metabolic syndrome.
- Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial.
- Absence of polycystic ovary syndrome features in human immunoDeficiency virus-infected women despite significant hyperinsulinemia and truncal adiposity.
- Metabolic syndrome and cardiovascular disease in patients with human immunoDeficiency virus.
- Medical findings in outpatients with anorexia nervosa.
- Nocturnal ghrelin pulsatility and response to Growth hormone secretagogues in healthy men.
- Relation of leptin pulse dynamics to fat distribution in HIV-infected patients.
- Regulation of adiponectin in human immunoDeficiency virus-infected patients: relationship to body composition and metabolic indices.
- Pathophysiology and management of cardiovascular disease in patients with HIV.
- Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV.
Schools
University Of Rochester
Colum Presby
Massachusetts General Hospital
Conditions Treated
- Acromegaly and Gigantism
- Adrenal Insufficiency
- Craniopharyngioma
- Diabetes Insipidus
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Elected Member
Education
-
New York Presbyterian Hospital - Columbia Campus -
University of Rochester School of Medicine and Dentistry
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1457342099 | |
| NPPES Provider LastName | GRINSPOON | |
| NPPES Provider FirstName | STEVEN | |
| NPPES Provider ZIPCode | 021142621 | |
| NPPES Provider State | MA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 224.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457342099 |
| Last Name Of The Provider | GRINSPOON |
| First Name Of The Provider | STEVEN |
| View All |
Similar Doctors
|
|
Dr. Ellen Marqusee, MD
 This Doctor is OpenDoctor Recommended.
|